Format

Send to

Choose Destination
Vaccine. 2013 Apr 8;31(15):1892-7. doi: 10.1016/j.vaccine.2013.01.024. Epub 2013 Jan 29.

Chlamydia trachomatis control requires a vaccine.

Author information

1
University of British Columbia and the British Columbia Centre for Disease Control, Vancouver, Canada. robert.brunham@bccdc.ca

Abstract

As the most common reported communicable disease in North America and Europe, Chlamydia trachomatis is the focus of concerted public health control efforts based on screening and treatment. Unexpectedly control efforts are accompanied by rising reinfection rates attributed in part to arresting the development of herd immunity. Shortening the duration of infection through the testing and treatment program is the root cause behind the arrested immunity hypothesis and because of this a vaccine will be essential to control efforts. Advances in Chlamydia vaccinomics have revealed the C. trachomatis antigens that can be used to constitute a subunit vaccine and a vaccine solution appears to be scientifically achievable. We propose that an accelerated C. trachomatis vaccine effort requires coordinated partnership among academic, public health and private sector players together with a commitment to C. trachomatis vaccine control as a global public health priority.

PMID:
23375977
PMCID:
PMC4148049
DOI:
10.1016/j.vaccine.2013.01.024
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center